Calendar An icon of a desk calendar. Cancel An icon of a circle with a diagonal line across. Caret An icon of a block arrow pointing to the right. Email An icon of a paper envelope. Facebook An icon of the Facebook "f" mark. Google An icon of the Google "G" mark. Linked In An icon of the Linked In "in" mark. Logout An icon representing logout. Profile An icon that resembles human head and shoulders. Telephone An icon of a traditional telephone receiver. Tick An icon of a tick mark. Is Public An icon of a human eye and eyelashes. Is Not Public An icon of a human eye and eyelashes with a diagonal line through it. Pause Icon A two-lined pause icon for stopping interactions. Quote Mark A opening quote mark. Quote Mark A closing quote mark. Arrow An icon of an arrow. Folder An icon of a paper folder. Breaking An icon of an exclamation mark on a circular background. Camera An icon of a digital camera. Caret An icon of a caret arrow. Clock An icon of a clock face. Close An icon of the an X shape. Close Icon An icon used to represent where to interact to collapse or dismiss a component Comment An icon of a speech bubble. Comments An icon of a speech bubble, denoting user comments. Comments An icon of a speech bubble, denoting user comments. Ellipsis An icon of 3 horizontal dots. Envelope An icon of a paper envelope. Facebook An icon of a facebook f logo. Camera An icon of a digital camera. Home An icon of a house. Instagram An icon of the Instagram logo. LinkedIn An icon of the LinkedIn logo. Magnifying Glass An icon of a magnifying glass. Search Icon A magnifying glass icon that is used to represent the function of searching. Menu An icon of 3 horizontal lines. Hamburger Menu Icon An icon used to represent a collapsed menu. Next An icon of an arrow pointing to the right. Notice An explanation mark centred inside a circle. Previous An icon of an arrow pointing to the left. Rating An icon of a star. Tag An icon of a tag. Twitter An icon of the Twitter logo. Video Camera An icon of a video camera shape. Speech Bubble Icon A icon displaying a speech bubble WhatsApp An icon of the WhatsApp logo. Information An icon of an information logo. Plus A mathematical 'plus' symbol. Duration An icon indicating Time. Success Tick An icon of a green tick. Success Tick Timeout An icon of a greyed out success tick. Loading Spinner An icon of a loading spinner. Facebook Messenger An icon of the facebook messenger app logo. Facebook An icon of a facebook f logo. Facebook Messenger An icon of the Twitter app logo. LinkedIn An icon of the LinkedIn logo. WhatsApp Messenger An icon of the Whatsapp messenger app logo. Email An icon of an mail envelope. Copy link A decentered black square over a white square.

Doosan Babcock’s £25m Angus contract for GSK Active Pharmaceutical Ingredients plant in Montrose

An impression of the new Active Pharmaceutical Ingredients plant in Montrose, which Doosan Babcock has secured a £25m contract to build.
An impression of the new Active Pharmaceutical Ingredients plant in Montrose, which Doosan Babcock has secured a £25m contract to build.

Specialist construction group Doosan Babcock has secured a £25 million contract to build new manufacturing facilities at pharmaceutical giant GSK’s Angus base.

The investment in the new Active Pharmaceutical Ingredients (API) plant was first announced in November 2013 during a meeting between Finance Secretary John Swinney and Roger Connor, GSK’s president of global manufacturing and supply.

A full planning application was approved by Angus councillors two months ago, and construction work has already begun.

Around 40 Doosan Babcock engineers are currently engaged in delivery of the project. The new complex, which will create around 25 new jobs once complete, is due to be fully operational by next summer.

The facility will support the production of active ingredients for three new GSK medicines for the management of respiratory conditions such as asthma and chronic obstructive pulmonary disease.

GSK’s existing Montrose operation, which was seen as being under threat of closure just a few years ago, produces medicines capable of treating more than 20 million patients every day.

Andrew Hunt, chief executive officer of Doosan Babcock, said he was delighted to be involved in such an important project.

The contract award follows a £6m investment by the firm, which also has strong links with the petrochemical plant at Grangemouth, in a new state-of-the-art process engineering centre at Renfrew.

Mr Hunt said: “This is a milestone contract for Doosan Babcock, and it is great to see that our major investment and ongoing work in Scotland’s pharmaceutical sector is being noticed.

“We are proud to be working with GSK on a project that will offer a major boost to the local economy, bring jobs to the region, and ultimately provide essential healthcare products for millions of people,” he added.

The new three-storey API building, which will stand on a 30m by 30m base and will be 16m tall at its highest point, will have the capability of producing up to 1,500kg of products each year, and its work will support that of a sister site in Singapore.